Bactericidal activity of levofloxacin against Mycoplasma pneumoniae

被引：14

作者：

Duffy, LB

Crabb, DM

Bing, X

Waites, KB ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA

[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 52卷 / 03期

关键词：

M; pneumoniae; levofloxacin; fluoroquinolones; bactericidal activity; respiratory tract infections;

D O I：

10.1093/jac/dkg365

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：527 / 528

页数：3

共 6 条

[1] Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas [J].

Bebear, CM ;

Renaudin, H ;

Bryskier, A ;

Bebear, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1980-1982

[2] Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp. [J].

Duffy, LB ;

Crabb, D ;

Searcey, K ;

Kempf, MC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 :29-33

[3] In vitro activities of moxifloxacin and ether fluoroquinolones against Mycoplasma pneumoniae [J].

Hamamoto, K ;

Shimizu, T ;

Fujimoto, N ;

Zhang, Y ;

Arai, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1908-1910

[4] Susceptibilities of Mycoplasma hominis, M-pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones [J].

Kenny, GE ;

Cartwright, FD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2604-2608

[5]

Talkington DE, 2001, EMERGING INFECTIONS 5, P57

[6] In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas [J].

Waites, KB ;

Crabb, DM ;

Bing, X ;

Duff, LB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) :161-165

← 1 →